Gingival Fibromatosis 2
2 drugs in active Gingival Fibromatosis 2 trials · Updated 18 Nov 2026
Furthest along
1 in Phase 2
1 in Phase 1
Next Phase 3 result
None yet
Drugs
2
In active trials, any stage
Trials
2 active
No sub-diseases
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | — | |||
| Also tested for | Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Mar 2031Phase 1 trial completes | |||
| Next date | 1 Mar 2031 · Phase 1 trial completes | ||||
| Also tested for | Non-Small Cell Lung Cancer, Pancreatic Cancer and 2 more | ||||
| Open drug page | |||||
About
- Summary
- 2 drugs are in active Gingival Fibromatosis 2 trials. Updated 18 Nov 2026.
- Registry term
- Fibromatosis, Gingival, 2
- Counts
- Active trials the registry tags with the term or a term under it, at any stage. A search also reads trial titles and drug names, so its counts differ.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026